GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (ASX:SIG) » Definitions » Cash Ratio

Sigma Healthcare (ASX:SIG) Cash Ratio : 0.96 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sigma Healthcare Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Sigma Healthcare's Cash Ratio for the quarter that ended in Jan. 2024 was 0.96.

Sigma Healthcare has a Cash Ratio of 0.96. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Sigma Healthcare's Cash Ratio or its related term are showing as below:

ASX:SIG' s Cash Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.07   Max: 0.96
Current: 0.96

During the past 13 years, Sigma Healthcare's highest Cash Ratio was 0.96. The lowest was 0.03. And the median was 0.07.

ASX:SIG's Cash Ratio is ranked better than
76.04% of 96 companies
in the Medical Distribution industry
Industry Median: 0.23 vs ASX:SIG: 0.96

Sigma Healthcare Cash Ratio Historical Data

The historical data trend for Sigma Healthcare's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Cash Ratio Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.03 0.07 0.03 0.96

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.03 0.03 0.96

Competitive Comparison of Sigma Healthcare's Cash Ratio

For the Medical Distribution subindustry, Sigma Healthcare's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare's Cash Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Cash Ratio falls into.



Sigma Healthcare Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Sigma Healthcare's Cash Ratio for the fiscal year that ended in Jan. 2024 is calculated as:

Cash Ratio (A: Jan. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=356.496/371.28
=0.96

Sigma Healthcare's Cash Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash Ratio (Q: Jan. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=356.496/371.28
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare  (ASX:SIG) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Sigma Healthcare Cash Ratio Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (ASX:SIG) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.